David Barnett (D.J.M.)
Recent publications
-
Barnett, D., Thijs, C., Mommers, M., Endika, M., Klostermann, C., Schols, H., Smidt, H., Nauta, A., Arts, I., & Penders, J. (2025). Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study. Gut Microbes, 17(1), Article 2485326. https://doi.org/10.1080/19490976.2025.2485326More information about this publication
-
Endika, M. F., Barnett, D. J. M., Olmos, E. M., Ter Braak, C. J. F., Arts, I. C. W., Penders, J., Nauta, A., Leemhuis, H., Venema, K., & Smidt, H. (2025). Assessing the potential for non-digestible carbohydrates toward mitigating adverse effects of antibiotics on microbiota composition and activity in an in vitro colon model of the weaning infant. FEMS microbiology ecology, 101(4), Article fiaf028. https://doi.org/10.1093/femsec/fiaf028More information about this publication
-
Hillege, L. E., Barnett, D. J. M., Ziemons, J., Aarnoutse, R., de Vos-Geelen, J., van Geel, R., de Boer, M., van Riet, Y. E. A., Vincent, J., Penders, J., & Smidt, M. L. (2025). The gut microbiota during tamoxifen therapy in patients with breast cancer. Scientific Reports, 15(1), Article 7874. https://doi.org/10.1038/s41598-025-91734-1More information about this publication
-
Ziemons, J., Hillege, L. E., Aarnoutse, R., de Vos-Geelen, J., Valkenburg-van Iersel, L., Mastenbroek, J., van Geel, R., Barnett, D. J. M., Rensen, S. S., van Helvoort, A., Dopheide, L. H. J., Roeselers, G., Penders, J., Smidt, M. L., & Venema, K. (2024). Prebiotic fibre mixtures counteract the manifestation of gut microbial dysbiosis induced by the chemotherapeutic 5-Fluorouracil (5-FU) in a validated in vitro model of the colon. BMC Microbiology, 24(1), Article 222. https://doi.org/10.1186/s12866-024-03384-4More information about this publication
-
Endika, M. F., Barnett, D. J. M., Klostermann, C. E., Kok, N., Schols, H. A., Nauta, A., Arts, I. C. W., Penders, J., Venema, K., & Smidt, H. (2024). Seeding and feeding milestones: the role of human milk microbes and oligosaccharides in the temporal development of infant gut microbiota. Gut Microbiome, 5. Advance online publication. https://doi.org/10.1017/gmb.2024.5More information about this publication
-
Barnett, D. J. M. (2024). Perturbing and protecting the infant gut: exploring the impacts of antibiotics and oligosaccharides on gut microbiota and child health. [Doctoral Thesis, Maastricht University]. Maastricht University. https://doi.org/10.26481/dis.20241205dbMore information about this publication
-
Endika, M. F., Barnett, D. J. M., Klostermann, C. E., Schols, H. A., Arts, I. C. W., Penders, J., Nauta, A., Smidt, H., & Venema, K. (2023). Microbiota-dependent influence of prebiotics on the resilience of infant gut microbiota to amoxicillin/clavulanate perturbation in an in vitro colon model. Frontiers in microbiology, 14(1), Article 1131953. https://doi.org/10.3389/fmicb.2023.1131953More information about this publication
-
Barnett, D. J. M., Endika, M. F., Klostermann, C. E., Gu, F., Thijs, C., Nauta, A., Schols, H. A., Smidt, H., Arts, I. C. W., & Penders, J. (2023). Human milk oligosaccharides, antimicrobial drugs, and the gut microbiota of term neonates: observations from the KOALA birth cohort study. Gut Microbes, 15(1), Article 2164152. https://doi.org/10.1080/19490976.2022.2164152More information about this publication
-
Bich, V. T. N., Le, N. G., Barnett, D., Chan, J., van Best, N., Tien, T. D., Anh, N. T. H., Hoang, T. H., van Doorn, H. R., Wertheim, H. F. L., & Penders, J. (2022). Moderate and transient impact of antibiotic use on the gut microbiota in a rural Vietnamese cohort. Scientific Reports, 12(1), Article 20189. https://doi.org/10.1038/s41598-022-24488-9More information about this publication
-
Aarnoutse, R., Ziemons, J., de Vos-Geelen, J., Valkenburg-van Iersel, L., Wildeboer, A. C. L., Vievermans, A., Creemers, G.-J. M., Baars, A., Vestjens, H. J. H. M. J., Le, G. N., Barnett, D. J. M., Rensen, S. S., Penders, J., & Smidt, M. L. (2022). The Role of Intestinal Microbiota in Metastatic Colorectal Cancer Patients Treated With Capecitabine. Clinical Colorectal Cancer, 21(2), E87-E97. https://doi.org/10.1016/j.clcc.2021.10.004More information about this publication